Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Philogen SpAMIL:PHIL -2.51%49 3-Year Share Buyback Ratio is 0.10 as of Dec. 2025, which is 50% below its 10-year median of 0.20. GuruFocus rates MIL:PHIL with a GF Score™ of 49/100 and a GF Value™ of €233.12 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,190 Biotechnology companies, Philogen SpA ranks better than 92.86% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Philogen SpA's current 3-Year Share Buyback Ratio was 0.10%.
The historical rank and industry rank for Philogen SpA's 3-Year Share Buyback Ratio or its related term are showing as below:
MIL:PHIL'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: 0.1 Med: 0.2 Max: 0.3
Current: 0.1
During the past 6 years, Philogen SpA's highest 3-Year Share Buyback Ratio was 0.30%. The lowest was 0.10%. And the median was 0.20%.
MIL:PHIL's 3-Year Share Buyback Ratio is ranked better than 92.86% of 1190
companies
in the Biotechnology industry
Industry Median: -11.75
vs MIL:PHIL: 0.10
Philogen SpA (MIL:PHIL) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Philogen SpA 3-Year Share Buyback Ratio Related Terms
MIL:PHIL vs VRTX, REGN, RVMD: 3-Year Share Buyback Ratio Comparison
For the Biotechnology subindustry, Philogen SpA's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Philogen SpA 3-Year Share Buyback Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Philogen SpA's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Philogen SpA's 3-Year Share Buyback Ratio falls into.
Philogen SpA 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.10 mean?
Philogen SpA (MIL:PHIL) has a 3-Year Share Buyback Ratio of 0.10 as of Dec. 2025. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Philogen SpA and its competitors. This is 50% below median its historical median of 0.20. Over the past decade, Philogen SpA's 3-Year Share Buyback Ratio has ranged from 0.10 to 0.30. According to the industry distribution chart, Philogen SpA ranks #85 out of 1190 companies in the Biotechnology industry, placing it in the top 7.1%.
Is Philogen SpA's 3-Year Share Buyback Ratio too high?
Philogen SpA's current 3-Year Share Buyback Ratio of 0.10 is 50% below median its 10-year median of 0.20. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.30. Based on the distribution chart, Philogen SpA ranks #85 out of 1190 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Philogen SpA has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's 3-Year Share Buyback Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Philogen SpA ranks #85 out of 1190 companies for 3-Year Share Buyback Ratio. This places Philogen SpA in the top 7% of its industry — outperforming the majority of peers. Historically, Philogen SpA's own 3-Year Share Buyback Ratio has ranged from 0.10 to 0.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Biotechnology company?
A good 3-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Philogen SpA and its competitors. Philogen SpA's current 3-Year Share Buyback Ratio is 0.10, which is 50% below median its own 10-year median of 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €233.12, compared to a current price of €23.30 — trading 90% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.10, which is 50% below median its 10-year median of 0.20. Philogen SpA's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current 3-Year Share Buyback Ratio is 0.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Philogen SpA (MIL:PHIL) Overvalued in 2026?
Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued.
The current stock price of €23.30 is trading 90% below its estimated GF Value™ of €233.12.
GuruFocus considers Philogen SpA to be Possible Value Trap.
Key valuation signals for MIL:PHIL:
3-Year Share Buyback Ratio: 0.10 (50% below median its 10-year median of 0.20)
GF Value™: €233.12 vs. price of €23.30 (90% below fair value)
No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
49GF Score
Get the complete analysis for MIL:PHIL
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PHIL has been successfully added to your 
